Light Horse Therapeutics (Series A)
Funding Details
- Date Award
- May 19, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $62,000,000
Company Info
- Company Description
- Light Horse Therapeutics is focused on developing small molecule drugs targeting diseases such as cancer by identifying novel functional sites in disease-critical proteins.
- Market
- Pharmaceuticals
- Location
- San Diego, California, United States
- Coinvestors
- Versant Ventures, Mubadala Capital, Bristol Myers Squibb, Taiho Ventures, AbbVie